Vote Scores

Home / Companies / Aadi Bioscience, Inc. / 28 Feb 2025

Meeting · year to 30 June 202558 filers reporting

Aadi Bioscience, Inc.: meeting of 28 Feb 2025

Votes reported on Form N-PX, item by item

58 Form N-PX filers reported votes at the Aadi Bioscience, Inc. meeting of 28 Feb 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on pay tied to a merger or sale

72 vote records from 57 filers. 0 of the 56 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.2% for0.0% against1.8% other0.0% against management57 filers100.0% for0.0% against0.0% against management10,960,781 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 13 filers. 0 of the 13 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management13 filers100.0% for0.0% against0.0% against management1,290,222 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 13 filers. 11 of the 13 filers that marked the item either way voted against management.

15.4% for84.6% against84.6% against management13 filers58.5% for41.5% against41.5% against management1,290,222 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

23 vote records from 15 filers. 13 of the 15 filers that marked the item either way voted against management.

6.7% for86.7% against6.7% other86.7% against management15 filers0.1% for99.9% against99.9% against management1,291,786 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

20 vote records from 13 filers. 3 of the 13 filers that marked the item either way voted against management.

76.9% for23.1% against23.1% against management13 filers82.4% for17.6% against17.6% against management1,290,222 reported shares, counted once per item in this group

How the largest families voted

Family1. Merger pay
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
American CenturyFor
EquitableFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
Goldman SachsFor
PGIM and PrudentialFor
Jackson National fundsFor
Northern Trust and FlexSharesFor
Lincoln FinancialFor
BNY MellonFor
Federated HermesFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Aadi Bioscience, Inc. meeting?

58 Form N-PX filers reported votes at the meeting of 28 Feb 2025. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Aadi Bioscience, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Aadi Bioscience, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Aadi Bioscience, Inc. with a meeting date within three days of 28 Feb 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.